Exemestane is prescribed for the treatment of early-stage breast cancer in postmenopausal women (those who have undergone menopause, signified by the cessation of monthly menstrual periods). It is specifically recommended for women who have already undergone 2 to 3 years of treatment with tamoxifen (Nolvadex). Additionally, this medication is used to address breast cancer in postmenopausal women whose condition has deteriorated while on tamoxifen therapy.

Finasteride (Proscar) is employed either on its own or in conjunction with another medication like doxazosin (Cardura) to address benign prostatic hypertrophy (BPH), characterized by the enlargement of the prostate gland. It is instrumental in alleviating BPH symptoms such as frequent and difficult urination while potentially reducing the risk of acute urinary retention, which is the sudden inability to urinate. Furthermore, it may lower the likelihood of requiring prostate surgery.

Flarex Ophthalmic Solution 0.1% is a trusted and effective ophthalmic medication designed to provide relief and treatment for various eye conditions. This sterile, clear, and colorless solution contains the active ingredient fluorometholone, a corticosteroid known for its potent anti-inflammatory properties. Flarex is specifically formulated to address ocular inflammation and associated symptoms.